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Rheumatoid arthritis (RA) is a complex polygenic inflammatory disease associated with accelerated athero-
sclerosis, which is the main cause of increased cardiovascular (CV) morbidity and mortality in RA patients.
CARD8 is a constituent of inflammasome, which regulates interleukin 1-beta production, and has been asso-
ciated with a worse disease course in early RA. One thousand six hundred twenty-one patients fulfilling the 1987
ACR classification criteria for RA and 1300 matched controls, were genotyped for the CARD8 rs2043211 (30T >A,
p.C10X) single-nucleotide polymorphism (SNP) using predesigned TaqMan SNP genotyping assay. The geno-
typing success rate in our study was greater than 94%. We assessed CARD8 rs2043211 gene polymorphism
results in 1530 Spanish RA patients in whom information on CV disease and CV risk factors was available at the
time of the study. Also, a subgroup of patients with no history of CV events (n= 276) was assessed for the
potential influence of the rs2043211 variant in the development of subclinical atherosclerosis, by measurement of
carotid intima-media thickness (IMT) and presence of carotid plaques. No statistically significant differences in
allele or genotype frequencies for the rs2043211 CARD8 gene variant between patients with RA and controls
were seen. Similarly, CARD8 rs2043211 (30T >A, p.C10X) SNP did not influence the development of CV events
or the risk of CV events throughout the time. Likewise, no significant association between this gene variant and
carotid IMT or the presence of plaques was found. In summary, our results do not support a role of the CARD8
rs2043211 gene variant in susceptibility to RA or in the development of CV disease in patients with RA.
Introduction
Rheumatoid arthritis (ra) is a complex autoimmunedisease associated with progressive disability, systemic
complications, and early death. Mortality is higher among
RA patients than among healthy people (Gonza´lez-Gay et al.,
2005a; Zinger et al., 2009), and cardiovascular (CV) compli-
cations remain a major challenge (McInnes and Schett, 2011).
Accelerated atherosclerosis is the main cause of increased CV
morbidity and mortality in RA patients (Bartoloni et al.,
2011). Besides traditional CV risk factors, chronic systemic
inflammation plays a pivotal role in the development of ac-
celerated atherosclerosis observed in RA patients (Dessein
et al., 2005; Gonza´lez-Gay et al., 2005b; Nurmohamed, 2009).
Fontalba et al. found that CARD8 (also known as TUCAN)
p.C10X polymorphism influenced the nuclear factor kB
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(NF-kB) transcriptional activity and was associated with RA
severity (Fontalba et al., 2007). Furthermore, epistatic inter-
actions have been found between components of the in-
flammasome, such as NLRP3 and CARD8, and ACPA-
positive RA and a more severe disease course (Kastbom et al.,
2008). The protein encoded by this gene (CARD8) belongs to
the caspase recruitment domain (CARD)-containing family of
proteins, which are involved in pathways leading to activa-
tion of caspases or NF-kB. This protein may be a component
of the inflammasome, a protein complex that plays a role in
the activation of proinflammatory caspases. It is thought that
this protein acts as an adaptor molecule that negatively reg-
ulates NF-kB activation, CASP1-dependent IL1b secretion,
and apoptosis. A single-nucleotide polymorphism (SNP)
rs2043211 changing cysteine at codon 10 to a premature ter-
mination codon (c.30T>A; p.C10X) in this gene was found to
be associated with inflammatory bowel disease (McGovern
et al., 2006; Fisher et al., 2007) and RA severity and a worse
disease course (Fontalba et al., 2007; Kastbom et al., 2010).
The present study aimed to assess the influence of CARD8
rs2043211 (c.30T >A) gene variant in the susceptibility to and
risk of CV disease in a large cohort of Spanish RA patients.
Patients and Methods
Patients and study protocol
A cohort of 1621 RA Spanish patients were included in the
present study. Blood samples were obtained from patients
recruited from Hospital Xeral-Calde, Hospital Universitario
Marque´s de Valdecilla, Hospital Universitario Bellvitge, and
Hospital Universitario La Paz, Hospital de La Princesa and
Hospital Clı´nico San Carlos from Madrid. The study was
approved by the ethics committee of the corresponding
hospitals and a subject’s written consent was obtained in all
the cases, according to the declaration of Helsinki. All the
patients fulfilled the 1987 American College of Rheumatol-
ogy criteria for the classification of RA (Arnett et al., 1988).
One thousand three hundred bone marrow and blood
donors from the National Repository DNA Bank (University
of Salamanca), matched by age and sex from the corre-
sponding regions, were selected as healthy controls.
Information on the main demographical data, clinical
characteristics of the patients enrolled in the study, CV risk
factors, and CV events of patients is shown in Table 1.
When the study was performed, 337 (20.79%) of the pa-
tients had experienced clinically evident CV events: ischemic
heart disease (154 patients, 9.54%), heart failure (90 patients,
5.90%), cerebrovascular accident (75 patients, 4.64%), or
peripheral arteriopathy (38 patients, 2.42%). Traditional
CV risk factors were established as previously described
(Gonza´lez-Gay et al., 2007; Gonza´lez-Juanatey et al., 2009).
Smoking habit encompassed to those patients who smoked
at the time of disease diagnosis, during the follow-up or who
had smoked within the 10 years before the onset of RA
symptoms or the disease diagnosis.
Patients with CV events were older at the time of disease
diagnosis, were more likely to be men and more often had
hypertension, diabetes mellitus, dyslipidemia, and obesity
(Table 1). Moreover, smoking habit defined as above, was
more frequent in men than in women RA patients (45.82% vs.
22.81%). Epidemiological studies have shown that among
environmental factors, cigarette smoking is one of the most
relevant causes involved in RA pathogenesis (Silman and
Pearson, 2002; Stolt et al., 2003; Klareskog et al., 2006; Bang
et al., 2010; Innala et al., 2011). It seems to play a relevant role
in disease induction and progression, particularly in pre-
disposed individuals (Bartoloni et al., 2010).
To determine the potential association between the
CARD8 rs2043211 variant and the presence of subclinical
atherosclerosis, between March 2007 and September 2010, a
random subgroup of patients from Lugo and Santander
(n= 276) with no previous history of CV events was selected.
Carotid ultrasonography studies were performed to deter-
mine the carotid artery intima-media thickness (IMT) and
plaques as described elsewhere (Gonza´lez-Juanatey et al.,
2006; Gonza´lez-Gay et al., 2008).
Genotyping
DNA from patients was obtained from peripheral blood
using standard methods. SNP rs2043211 consists in an A-to-
T transversion in exon 5 of the CARD8 gene predicted to
Table 1. Demographic Characteristics of Rheumatoid Arthritis Patients Included in the Study
Clinical feature % (n/N)
With CV
events, % (n)
Without CV
events, % (n) p-value
Main characteristics
Women 74.09 (1201/1621) 62.61 (210) 77.06 (991) < 10 - 6
Age of patients at the time of disease diagnosis,
years, median (IQR)
54 (43–64) 62.4 (53.6–70) 52 (41–61) < 10–3
Time follow-up, years, median (IQR) 10.4 (5–17) 11 (6–19) 10 (5–16) 0.30
Anti-CCP-positive 57.62 (760/1319) 51.39 (129) 59.08 (631) 0.017
Rheumatoid factor-positive 69.16 (1101/1592) 69.11 (217) 69.17 (884) 0.98
Cardiovascular risk factors
Hypertension 40.87 (658/1610) 66.36 (219) 34.30 (439) < 10–7
Diabetes mellitus 13.33 (214/1605) 23.40 (77) 10.74 (137) < 10–7
Dyslipidemia 38.93 (626/1608) 55.39 (185) 34.62 (441) < 10–7
Obesity 22.95 (350/1525) 28.66 (88) 21.51 (262) 0.008
Smoking habit 28.77 (443/1540) 34.07 (108) 27.39 (335) 0.019
Cardiovascular events 20.79 (337/1621) 100 (337) NA
Except where indicated otherwise, values are % (n/N).
CV, cardiovascular; IQR, interquartile range; Anti-CCP, anti-cyclic citrullinated peptide antibodies; NA, not applicable.
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result in a Cys10-to-ter (C10X) substitution (Bagnall et al.,
2008). The p.C10X polymorphism in CARD8 (c.30T/A,
rs2043211) was analyzed using TaqMan Assays-on-Demand
and TaqMan Genotyping Master Mix, and analyzed in the
ABI 7900HT Fast Real-Time PCR System, according to the
manufacturer’s instructions (Applied Biosystems). Negative
controls and duplicate samples were included to check the
accuracy of genotyping.
Statistical analysis
All genotype data were checked for deviation from
Hardy–Weinberg equilibrium (HWE) using http://ihg.gsf
.de/cgi-bin/hw/hwa1.pl. Both allelic and genotypic fre-
quencies were calculated and compared by the w2 or Fisher
tests using the StatsDirect software V2.6.6 (StatsDirect;
http://www.statsdirect.com: StatsDirect 2008). Strength of
associations between CV events and genotypes or alleles
were estimated using odds ratios (OR) and 95% confidence
intervals (CI), via multiple logistic regression; estimates were
further adjusted for sex, age at RA diagnosis, time of follow-
up, and classic CV risk factors (hypertension, diabetes mel-
litus, dyslipidemia, obesity, and smoking habit).
The relationship between CARD8 rs2043211 genotypes
and CV events was analyzed via multivariate Cox regression
adjusting for age at RA diagnosis, sex, and classic CV risk
factors (hypertension, diabetes mellitus, dyslipidemia, obe-
sity, and smoking habit); patients that had not experienced a
CV event at the end of follow-up were considered as cen-
sored. Results were expressed as the hazard ratio (HR) with
its 95% CI.
The association between genotypes of the CARD8
rs2043211 variant and carotid IMT was tested using the
unpaired t test to compare between two groups, and one-
way analysis of variance (ANOVA) to compare among more
than two groups. Moreover, we also tested the association
between this parameter and alleles using analysis of covari-
ance (ANCOVA) adjusting for sex, age, and duration of the
disease at the time of the ultrasonography study, anticyclic
citrullinated peptide (CCP) antibody status, and traditional
CV risk factors.
All p-values refer to two-tailed tests, with p £ 0.05 consid-
ered statistically significant. All analyses were performed
with STATA statistical software 9.1 (Stata Corp.).
Statistical power for the study was calculated using CaTS -
Power Calculator for Two Stage Association Studies (http://
sph.umich.edu/csg/abecasis/CaTS/) (Skol et al., 2006).
Results
No deviation from HWE ( p > 0.5) in controls was detected
for CARD8 rs2043211 polymorphism; however, cases were
slightly out of HWE ( p = 0.041). The genotyping success rate
in our study was greater than 94%.
The distributions of genotypes or alleles between patients
and controls revealed no significant differences as shown in
Table 2, nor were there any differences in distribution in
individuals stratified for the presence or absence of anti-CCP
antibodies (data not shown). Anti-CCP positivity status has
been reported to be a risk factor for the development of
ischemic heart disease in RA patients (Lo´pez-Longo et al.,
2009), and epistatic interactions have been found between
components of the inflammasome, such as NLRP3 and
CARD8, and anti-CCP-positive RA and a more severe dis-
ease course (Kastbom et al., 2008).
Allele frequencies were in agreement with the ones pre-
viously published in other studies (Fontalba et al., 2007;
Schoultz et al., 2009; Pontillo et al., 2012) for European
populations.
The overall study (case–control association) has statistical
power equal or higher 98% to detect modest OR equal to 1.25
or higher, at the stated significance level (a= 0.05), and a
prevalence of RA in Spanish population 0.5% (Carmona
et al., 2002); in the case of the association with CV disease, the
statistical power reached 67%.
As shown in Table 2, no significant differences in the ge-
notype and allele frequencies were found when patients who
had experienced CV disease were compared with those who
had not suffered any kind of CV events.
In a further step, we constructed a logistic regression
model to explain the presence of CV disease according to the
CARD8 rs2043211 allele distribution, which was adjusted for
sex, age at the time of RA diagnosis, follow-up time from the
disease diagnosis, anti-CCP status, and traditional CV risk
factors (hypertension, diabetes mellitus, dyslipidemia, obe-
sity, and smoking habit) as potential confounders. However,
no significant association was found in the crude ( p= 0.67,
OR 0.96, 95% CI [0.80–1.16]) or adjusted model ( p= 0.55, OR
1.08, 95% CI [0.83–1.42]). Also, no association was detected
for the risk of developing each one of the CV disease com-
plications described before—heart failure, ischemic heart
disease, cerebrovascular accidents, or peripheral arteriopathy
(data not shown).
Likewise, no significant associations were detected when
we analyzed our cohort of patients by presence or not of
hypertension, diabetes mellitus, dyslipidemia, or anti-CCP
status (data not shown). Interestingly, in smokers patients—
that is individuals who smoked at the time of RA diagnosis,
during the follow-up or who had smoked within the 10 years
before the onset of RA symptoms or the disease diagnosis—
when we performed a logistic regression model adjusted for
sex, age at the time of RA diagnosis, follow-up time from the
disease diagnosis, anti-CCP status, and long-standing CV
risk factors, results disclosed a marginally significant asso-
ciation: p = 0.051, OR 1.61, 95% CI [0.99–2.63]. Results of
smokers T allele carriers in the adjusted logistic regression
model were as follows: p= 0.014, OR 2.60, 95% CI [1.21–5.60].
However, these results should be interpreted with caution
due to the small number of patients involved.
In a further step, we performed a Cox regression model to
account for the variation of risk of CV event through time
according to the CARD8 polymorphism. According to this
model, CARD8 genotypes are not associated with high risk
of CV event when adjusting for age at RA diagnosis, sex, and
CV risk factors. However, when analyzing nonsmoker pa-
tients, those carrying the T allele had a lower risk of
CV events than AA homozygous patients (AT genotype:
p = 0.49, HR = 0.66, 95% CI [0.46–1.00]; TT genotype: p= 0.24,
HR = 0.66, 95% CI [0.37–1.31]). It is noteworthy that T being
the minor allele, the number of patients with the TT geno-
type is lower, so it is more difficult to reach statistical sig-
nificance for this genotype. In smoker patients, the T allele
did not yield a decrease in the risk of CV event (AT geno-
type: p= 0.36, HR = 1.39, 95% CI [0.68–2.85]; TT genotype:
p = 0.27, HR = 1.66, 95% CI [0.68–4.05]). However, since the
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number of smoker patients was relatively small, no strong
conclusions could be reached about the trend to increased
risk displayed in this study.
Since carotid IMT and the presence of carotid plaques
have been found to be well predictors of the risk of CV
events in the extended follow-up of patients with RA
(Gonza´lez-Juanatey et al., 2009; Evans et al., 2011), in a further
step, we analyzed potential differences in the carotid IMT
and presence of carotid plaques in 276 RA patients with no
history of CV events stratified according to the rs2043211
CARD8 genotype and allele distribution.
Results of the comparison between the different genotypes
and allele frequencies of the CARD8 rs2043211 polymor-
phism according to carotid IMT were as follows:
Carotid IMT-mean (standard deviation): AA (n = 108)
0.73mm (0.15), AT (n= 144) 0.74mm (0.18), TT (n = 24) 0.75
(0.19); p = 0.85. Carriers of T allele (n= 168): carotid IMT:
0.74mm (0.18); p= 0.57.
No statistically significant differences were found when
allele frequencies of CARD8 rs2043211 gene variant were
analyzed according to this parameter in the ANOVA model:
A (n = 360) 0.74 (0.16), T (n = 192) 0.74 (0.18); p= 0.61. It was
also the case when association between the CARD8
rs2043211 polymorphism and results of carotid IMT were
adjusted for potential confounders like sex, age at the time of
the ultrasonography assessment, follow-up time, anti-CCP
status, and traditional CV risk factors (hypertension, diabetes
mellitus, dyslipidemia, obesity, and smoking habit) in the
ANCOVA model ( p= 0.43). Additionally, no association was
found when a logistic regression model was constructed to
explain the presence of carotid plaques according to the
CARD8 rs2043211 allele distribution ( p = 0.29, OR 0.82, 95%
CI [0.57–1.18]), which was adjusted for sex, age at the time of
RA diagnosis, follow-up time from the disease diagnosis,
anti-CCP status, and classic CV risk factors as potential
confounders: p= 0.82, OR 0.95, 95% CI [0.58–1.53].
Discussion
In this large Spanish cohort of RA patients, we were not
able to detect the influence of the rs2043211 CARD8 delete-
rious gene variant in the susceptibility to the disease, despite
data previously reported regarding involvement of this ge-
netic variant in disease severity (Fontalba et al., 2007) and
worse disease course in patients with RA (Kastbom et al.,
2010).
Several studies have shown lack of association of this
CARD8 genetic variant with several autoimmune diseases,
such as Crohn’s disease (Buning et al., 2008), type-1 diabetes
(Pontillo et al., 2010), or systemic lupus erythematosus
(Pontillo et al., 2012). Although some other studies have de-
tected positive associations (McGovern et al., 2006; Schoultz
et al., 2009; Roberts et al., 2010), to the best of our knowledge,
genome-wide association studies (GWAS) have not shown
associations between the CARD8 gene and autoimmune
diseases in general, and RA disease susceptibility or CV traits
in particular (www.genome.gov/gwastudies, accessed July
5th, 2012).
RA is a chronic inflammatory disease associated with in-
creased mortality, mainly due to accelerated coronary artery
and cerebrovascular atherosclerosis (Kaplan, 2006). Chronic
inflammation is a key factor in the atherogenesis process
observed in RA (Gonza´lez-Gay et al., 2007). Even in inactive
phases of the disease, dysregulated levels of cytokines are
present and in this way, promote vascular disease in RA
(Sattar et al., 2003). Our results do not support a role of
CARD8 rs2043211 gene variant in the development of CV
events, nor in subclinical atherosclerosis disease, assessed by
carotid IMT and presence of carotid plaques, in Spanish RA
patients. In keeping with our findings, a study in the New
Zealand population disclosed that the CARD8 SNP
rs2043211 minor allele only conferred a modest protective
effect against abdominal aortic aneurysm (Roberts et al.,
2011).
We have recently described that the NF-kB rs28362491
(- 94ATTG ins/del) gene variant influences the risk of CV
events in RA patients (Lo´pez-Mejias et al., 2012). NF-kB
transactivates the CARD8 gene, which may lead to a regu-
latory loop that controls NF-kB activation in response to
inflammatory stimuli (Fontalba et al., 2007). The activation
and translocation of NF-kB to the nucleus induces gene ex-
pression of TNF-a, pro-ILb and matrix metalloproteinases,
prototypic mediators of inflammation, and tissue degrada-
tion in RA (Makarov, 2001). In the Fontalba study with 91
RA patients, those who were homozygous carriers of the T
allele had a higher disease activity score, more extra-articular
manifestations comprising nodules, secondary Sjo¨gren syn-
drome, episcleritis, pericardial or pleural effusion, interstitial
Table 2. Genotypes and Minor Allele Frequencies of CARD8 rs2043211 Genetic Variant in Healthy Controls
and RA Patients, as Well as in RA Patients Stratified According to the Presence (With)
or Absence (Without) of CV Events
Genotypes
Subgroup AA AT TT MAF (%) p-valuea OR [95% CI]b
Controls (N = 1292) 577 (44.66) 582 (45.05) 133 (10.29) 32.82
RA patients (N = 1530) 669 (43.73) 712 (46.54) 149 (9.74) 33.01 0.88c 1.01 [0.90–1.13]c
Without CV events (n= 1208) 524 (43.38) 566 (46.85) 118 (9.77) 33.20
With CV events (n = 322) 145 (45.03) 146 (45.34) 31 (9.63) 32.30 0.67d 0.96 [0.79–1.16]d
Values are the number (percentage) unless otherwise indicated.
ap-Value for the allelic model.
bOdds ratio for the minor allele.
cWith respect to controls.
dComparing RA patients with RA patients without CV events.
RA, rheumatoid arthritis; CARD, caspase recruitment domain; MAF, minor allele frequency; OR, odds ratio; CI, confidence interval.
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lung disease, and systemic vasculitis, as well as a lower
probability of clinical remission (Fontalba et al., 2007).
Limitations of the study include, as in many other human
genetic studies, that sample size is fixed, and the phenotypes
studied are complex and involve multiple small-to-modest
effects of multiple genes and environmental factors. There-
fore, additional studies are needed to clarify the role of
inflammasome components and interactions between envi-
ronmental, hormonal, and genetic factors in the risk of CV
disease in RA patients.
Increased risk of CV disease is observed not only in RA,
but also in other chronic inflammatory rheumatic diseases,
such as ankylosing spondilitis, psoriatic arthritis, systemic
lupus erythematosus, and systemic sclerosis, among others
(Murdaca et al., 2012). Due to the potential implication of
CARD8 in inflammatory mechanisms that might potentially
influence or modulate the development of atherosclerosis
in these patients, further investigation is warranted to en-
lighten the possible role of the inflammasome components
in the development of atherosclerosis, which drive out to the
elevated CV morbidity and mortality seen in those pa-
tients. However, given the clearly pleiotropic nature of this
SNP, it is difficult to predict the direction of effect of any
association.
In summary, our results do not support an association
between the CARD8 rs2043211 gene polymorphism and
susceptibility to disease or risk of development of CV disease
in RA. Further studies are warranted to shed light on the
complex genetic influence in the development of the accel-
erated atherosclerosis and the increased morbidity and
mortality observed in patients with this disease.
Acknowledgments
We are indebted to all the patients and healthy controls
who kindly participated in this study. We are grateful to
Banco Nacional de ADN (University of Salamanca, Spain),
which supplied part of the control DNA samples. This work
was supported by grants from Fondo de Investigaciones
Sanitarias PI06-0024 and PS09/00748 (Spain), and by RETICS
Program, RD08/0075 (RIER) from Instituto de Salud Carlos
III (ISCIII), within the VI PN de I +D + i 2008–2011 (FEDER).
M.G.B. is a beneficiary of a grant from Fundacio´n Espan˜ola
de Reumatologı´a (FER).
Authors’ Contributions
M.G.B. and R.L.-M. carried out genotyping, participated
in the design of the study, data analysis, and drafted the
manuscript. J.A.M.-F., C.G.-V., A.B., D.P.-S., and R.B. par-
ticipated in the acquisition and interpretation of data. C.G.-J.,
A.C., S.C., A.M.O., and B.F.-G. have been involved in the
acquisition and interpretation of data and in revising it
critically for important intellectual content. J.L. carried out
the analysis and interpretation of the data. J.M. and M.A.G.-
G. have made substantial contributions to conception and
design of the study, acquisition of data, coordination, and
helped to draft the manuscript and have given final approval
of the version to be published.
Disclosure Statement
The authors declare that they have no conflicts of interest.
References
Arnett, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries,
J.F., Cooper, N.S., et al. (1988). The American Rheumatism
Association 1987 revised criteria for the classification of
rheumatoid arthritis. Arthritis Rheum 31, 315–324.
Bagnall, R.D., Roberts, R.G., Mirza, M.M., Torigoe, T., Prescott,
N.J., and Mathew, C.G. (2008). Novel isoforms of the CARD8
(TUCAN) gene evade a nonsense mutation. Eur J Hum Genet
16, 619–625.
Bang, S.Y., Lee, K.H., Cho, S.K., Lee, H.S., Lee, K.W., and Bae,
S.C. (2010). Smoking increases rheumatoid arthritis suscepti-
bility in individuals carrying the HLA-DRB1 shared epitope,
regardless of rheumatoid factor or anti-cyclic citrullinated
peptide antibody status. Arthritis Rheum 62, 369–377.
Bartoloni, E., Alunno, A., Luccioli, F., Moscatelli, S., Biscontini,
D., Santoboni, G., et al. (2010). Atherosclerotic vascular dam-
age and rheumatoid arthritis: a complex but intriguing link.
Expert Rev Cardiovasc Ther 8, 1309–1316.
Bartoloni, E., Shoenfeld, Y., and Gerli, R. (2011). Inflammatory
and autoimmune mechanisms in the induction of atheroscle-
rotic damage in systemic rheumatic diseases: two faces of the
same coin. Arthritis Care Res (Hoboken) 63, 178–183.
Buning, C., Schmidt, H.H., Molnar, T., Drenth, J.P., Fiedler, T.,
Gentz, E., et al. (2008). No association of the CARD8 (TUCAN)
c.30T>A (p.C10X) variant with Crohn’s disease: a study in 3
independent European cohorts. InflammBowel Dis 14, 332–337.
Carmona, L., Villaverde, V., Hernandez-Garcı´a, C., Ballina, J.,
Gabriel, R., and Laffon, A. (2002). The prevalence of rheu-
matoid arthritis in the general population of Spain. Rheuma-
tology (Oxford) 41, 88–95.
Dessein, P.H., Joffe, B.I., Veller, M.G., Stevens, B.A., Tobias, M.,
Reddi, K., et al. (2005) Traditional and nontraditional cardio-
vascular risk factors are associated with atherosclerosis in
rheumatoid arthritis. J Rheumatol 32, 435–442.
Evans, M.R., Escalante, A., Battafarano, D.F., Freeman, G.L.,
O’Leary, D.H., and del Rincon, I. (2011). Carotid atheroscle-
rosis predicts incident acute coronary syndromes in rheuma-
toid arthritis. Arthritis Rheum 63, 1211–1220.
Fisher, S.A., Mirza, M.M., Onnie, C.M., Soars, D., Lewis, C.M.,
Prescott, N.J., et al. (2007). Combined evidence from three
large British Association studies rejects TUCAN/CARD8 as an
IBD susceptibility gene. Gastroenterology 132, 2078–2080.
Fontalba, A., Martinez-Taboada, V., Gutierrez, O., Pipaon, C.,
Benito, N., Balsa, A., et al. (2007). Deficiency of the NF-kappaB
inhibitor caspase activating and recruitment domain 8 in
patients with rheumatoid arthritis is associated with disease
severity. J Immunol 179, 4867–4873.
Gonza´lez-Gay, M.A., Gonza´lez-Juanatey, C., Lo´pez-Diaz, M.J.,
Pineiro, A., Garcı´a-Porrua, C., Miranda-Filloy, J.A., et al. (2007).
HLA-DRB1 and persistent chronic inflammation contribute to
cardiovascular events and cardiovascular mortality in patients
with rheumatoid arthritis. Arthritis Rheum 57, 125–132.
Gonza´lez-Gay, M.A., Gonza´lez-Juanatey, C., and Martin, J.
(2005a). Rheumatoid arthritis: a disease associated with ac-
celerated atherogenesis. Semin Arthritis Rheum 35, 8–17.
Gonza´lez-Gay, M.A., Gonza´lez-Juanatey, C., Pineiro, A., Garcı´a-
Porrua, C., Testa, A., Llorca, J. (2005b). High-grade C-reactive
protein elevation correlates with accelerated atherogenesis in
patients with rheumatoid arthritis. J Rheumatol 32, 1219–1223.
Gonza´lez-Gay, M.A., Gonza´lez-Juanatey, C., Vazquez-
Rodriguez, T.R., Martin, J., and Llorca, J. (2008). Endothelial
dysfunction, carotid intima-media thickness, and accelerated
atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum
38, 67–70.
32 GARCI´A-BERMU´DEZ ET AL.
Gonza´lez-Juanatey, C., Llorca, J., Garcı´a-Porrua, C., Martin, J., and
Gonza´lez-Gay, M.A. (2006). Effect of anti-tumor necrosis factor
alpha therapy on the progression of subclinical atherosclerosis in
severe rheumatoid arthritis. Arthritis Rheum 55, 150–153.
Gonza´lez-Juanatey, C., Llorca, J., Martin, J., and Gonza´lez-Gay,
M.A. (2009). Carotid intima-media thickness predicts the de-
velopment of cardiovascular events in patients with rheuma-
toid arthritis. Semin Arthritis Rheum 38, 366–371.
Innala, L., Moller, B., Ljung, L., Magnusson, S., Smedby, T.,
Sodergren, A., et al. (2011). Cardiovascular events in early RA
are a result of inflammatory burden and traditional risk fac-
tors: a five year prospective study. Arthritis Res Ther 13, R131.
Kaplan, M.J. (2006). Cardiovascular disease in rheumatoid ar-
thritis. Curr Opin Rheumatol 18, 289–297.
Kastbom, A., Johansson, M., Verma, D., Soderkvist, P., and
Rantapaa-Dahlqvist, S. (2010). CARD8 p.C10X polymorphism
is associated with inflammatory activity in early rheumatoid
arthritis. Ann Rheum Dis 69, 723–726.
Kastbom, A., Verma, D., Eriksson, P., Skogh, T., Wingren, G.,
and Soderkvist, P. (2008). Genetic variation in proteins of the
cryopyrin inflammasome influences susceptibility and sever-
ity of rheumatoid arthritis (the Swedish TIRA project). Rheu-
matology (Oxford) 47, 415–417.
Klareskog, L., Stolt, P., Lundberg, K., Kallberg, H., Bengtsson,
C., Grunewald, J., et al. (2006). A new model for an etiology of
rheumatoid arthritis: smoking may trigger HLA-DR (shared
epitope)-restricted immune reactions to autoantigens modified
by citrullination. Arthritis Rheum 54, 38–46.
Lo´pez-Longo, F.J., Oliver-Minarro, D., de la Torre, I., Gonza´lez-
Diaz de Rabago, E., Sanchez-Ramon, S., Rodriguez-Mahou,
M., et al. (2009). Association between anti-cyclic citrullinated
peptide antibodies and ischemic heart disease in patients with
rheumatoid arthritis. Arthritis Rheum 61, 419–424.
Lo´pez-Mejias, R., Garcı´a-Bermu´dez, M., Gonza´lez-Juanatey, C.,
Castan˜eda, S., Miranda-Filloy, J.A., Gomez-Vaquero, C., et al.
(2012). NFKB1-94ATTG ins/del polymorphism (rs28362491)
is associated with cardiovascular disease in patients with
rheumatoid arthritis. Atherosclerosis 224, 426–429.
Makarov, S.S. (2001). NF-kappa B in rheumatoid arthritis: a
pivotal regulator of inflammation, hyperplasia, and tissue
destruction. Arthritis Res 3, 200–206.
McGovern,D.P., Butler,H.,Ahmad,T.,Paolucci,M.,vanHeel,D.A.,
Negoro, K., et al. (2006). TUCAN (CARD8) genetic variants and
inflammatory bowel disease. Gastroenterology 131, 1190–1196.
McInnes, I.B., and Schett, G. (2011). The pathogenesis of rheu-
matoid arthritis. N Engl J Med 365, 2205–2219.
Murdaca, G., Colombo, B.M., Cagnati, P., Gulli, R., Spano, F.,
and Puppo, F. (2012). Endothelial dysfunction in rheumatic
autoimmune diseases. Atherosclerosis 224, 309–317.
Nurmohamed, M.T. (2009). Cardiovascular risk in rheumatoid
arthritis. Autoimmun Rev 8, 663–667.
Pontillo, A., Brandao, L., Guimaraes, R., Segat, L., Araujo, J., and
Crovella, S. (2010). Two SNPs in NLRP3 gene are involved in
the predisposition to type-1 diabetes and celiac disease in a
pediatric population from northeast Brazil. Autoimmunity 43,
583–589.
Pontillo, A., Girardelli, M., Kamada, A.J., Pancotto, J.A., Donadi,
E.A., Crovella, S., et al. (2012). Polymorphisms in inflamma-
some genes are involved in the predisposition to systemic
lupus erythematosus. Autoimmunity 45, 271–278.
Roberts, R.L., Topless, R.K., Phipps-Green, A.J., Gearry, R.B.,
Barclay, M.L., and Merriman, T.R. (2010). Evidence of inter-
action of CARD8 rs2043211 with NALP3 rs35829419 in
Crohn’s disease. Genes Immun 11, 351–356.
Roberts, R.L., Van Rij, A.M., Phillips, L.V., Young, S., McCor-
mick, S.P., Merriman, T.R., et al. (2011). Interaction of the in-
flammasome genes CARD8 and NLRP3 in abdominal aortic
aneurysms. Atherosclerosis 218, 123–126.
Sattar, N., McCarey, D.W., Capell, H., and McInnes, I.B. (2003).
Explaining how ‘‘high-grade’’ systemic inflammation acceler-
ates vascular risk in rheumatoid arthritis. Circulation 108,
2957–2963.
Schoultz, I., Verma, D., Halfvarsson, J., Torkvist, L., Fredrikson,
M., Sjoqvist, U., et al. (2009). Combined polymorphisms in
genes encoding the inflammasome components NALP3 and
CARD8 confer susceptibility to Crohn’s disease in Swedish
men. Am J Gastroenterol 104, 1180–1188.
Silman, A.J., and Pearson, J.E. (2002). Epidemiology and ge-
netics of rheumatoid arthritis. Arthritis Res 4 Suppl 3, S265–
S272.
Skol, A.D., Scott, L.J., Abecasis, G.R., and Boehnke, M. (2006).
Joint analysis is more efficient than replication-based analysis
for two-stage genome-wide association studies. Nat Genet 38,
209–213.
Stolt, P., Bengtsson, C., Nordmark, B., Lindblad, S., Lundberg, I.,
Klareskog, L., et al. (2003). Quantification of the influence
of cigarette smoking on rheumatoid arthritis: results from a
population based case-control study, using incident cases.
Ann Rheum Dis 62, 835–841.
Zinger, H., Sherer, Y., and Shoenfeld, Y. (2009). Atherosclerosis
in autoimmune rheumatic diseases-mechanisms and clinical
findings. Clin Rev Allergy Immunol 37, 20–28.
Address correspondence to:
Miguel A. Gonza´lez-Gay, M.D., Ph.D.
Department of Rheumatology
Hospital Universitario Marque´s de Valdecilla, IFIMAV
Avenida de Valdecilla, s/n
39008 Santander
Spain
E-mail: miguelaggay@hotmail.com
Received for publication August 22, 2012; received in revised
form September 24, 2012; accepted September 24, 2012.
CARD8 IN RA SUSCEPTIBILITY AND RISK OF CV EVENTS 33
